In Practise Logo
In Practise Logo - Blue

Explore our full content library.

Moody's Analytics: M&A Integration, Brand Consolidation & Cross-Selling Challenges

Partner Interview
MoodysUSLarge CapRELX
Apr 24, 2026

RELX Elsevier: AI Integration in Clinical Decision Support

Partner Interview
RELXGBLarge CapClarivateJohn Wiley & Sons
Feb 2, 2026

RELX STM Division: Peer Review Process Value vs AI Competition

Partner Interview
RELXGBLarge CapWolters KluwerThomson ReutersJohn Wiley & Sons
Jan 29, 2026

Research Solutions: Headless API, Publishers' Agreements & M&A

Partner Interview
Research SolutionsUSSmall CapRELXClarivate
Dec 22, 2025

Research Solutions: A Chief Clinical Officer Perspective

Partner Interview
Research SolutionsUSSmall CapClarivateRELX
Dec 17, 2025

Research Solutions: Scite.ai Adoption & Advantages Over Competitors from a US University Perspective

Partner Interview
Research SolutionsUSSmall CapRELXClarivate
Dec 13, 2025

Research Solutions: Products Overview & Market Dynamics

Partner Interview
Research SolutionsUSSmall CapClarivateRELX
Dec 1, 2025

Research Solutions: AI Impact on Research Workflows & RELX's Scopus

Partner Interview
Research SolutionsUSSmall CapRELXClarivate
Nov 30, 2025

Wolters Kluwer: Pricing Vulnerabilities

Partner Interview
Wolters KluwerNLLarge CapRELXATHENAHEALTH INCNextGen Healthcare
Oct 31, 2025

Wolters Kluwer: UpToDate Pricing & Gen AI Threats

Partner Interview
Wolters KluwerNLLarge CapRELXVeradigm
Aug 18, 2025

Wolters Kluwer: UpToDate’s Value Proposition & Retention

Partner Interview
Wolters KluwerNLLarge CapRELXVeradigm
Aug 18, 2025

RELX: LexisNexis Risk Solutions Portfolio

Partner Interview
RELXLondon Stock Exchange GroupMoodysS&P GlobalExperianThomson ReutersNetwork EffectsUnique IP & Brands
Jun 23, 2025

Moody's: Analytics Product Offering & Customer Perspective

Partner Interview
MoodysRELXS&P GlobalThomson Reuters
May 19, 2025

Wilmington: Product Strategy & Portfolio Quality

IP Icon
IP Interview
WilmingtonGBSmall CapRELXExperianNetwork EffectsUnique IP & Brands
Jan 15, 2025

You've reached the end